Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Cisatracurium Besylate NDC 0703-2045 by Teva Parenteral Medicines, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image - image 1
image - image 2
image - image 3
image - image 4
Cisatracurium Besylate Injection, USP is a medication provided in 10x5 ml Single-dose Vials, must only be administered intravenously and is a paralyzing agent that can cause respiratory arrest. Facilities for artificial respiration must be immediately available.*
image - image 5
This document appears to be a warning label for the drug Cisatracurium Besylate Injection, used for intravenous injection, manufactured by Jameson Pharmaceutical Co. in China. The drug is labelled as a paralyzing agent that may cause respiratory arrest, and facilities for artificial respiration should be immediately available. The injection contains 20 mg/10 mL of cisatracurium besylate and 0.9% benzyl alcohol as a preservative. The drug comes in 10x 10 mL multiple-dose vials.*
image - image 6
Cisatracurium Besylate Injection, USP is a paralyzing agent, which can cause respiratory arrest. This injection is for Intravenous use and is for ICU use only. Facilities for artificial respiration must be immediately available. The package contains 10x20 mL single-dose vials.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.